Stock

Ajanta Pharma board okays buyback

Our Burea Chennai | Updated on November 03, 2020 Published on November 03, 2020

The board of Ajanta Pharma on Tuesday approved a proposal to buyback ₹135.97 crore worth shares. Accordingly the company plans to buyback 7.35 lakh shares (representing 0.84 per cent of the total paid-up share capital) at ₹1,850 a share. The buyback would be on a proportionate basis through a tender offer route. The board has taken note of the intention of certain members of promoters and promoter group of the company to participate in the proposed buyback. The board has fixed November 13 as the record date for determining the eligible shareholders to participate in the buyback. Shares of Ajanta Pharma closed ₹1,609.95 on the BSE.

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

Published on November 03, 2020
  1. Comments will be moderated by The Hindu Business Line editorial team.
  2. Comments that are abusive, personal, incendiary or irrelevant cannot be published.
  3. Please write complete sentences. Do not type comments in all capital letters, or in all lower case letters, or using abbreviated text. (example: u cannot substitute for you, d is not 'the', n is not 'and').
  4. We may remove hyperlinks within comments.
  5. Please use a genuine email ID and provide your name, to avoid rejection.